All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @cliffthewelder on TikTok · 87s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @cliffthewelder's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Yeah lights up
  2. 0:04It's time to grind where the weights align and I clear my mind I am playground where I break my chains every rep
  3. 0:11I take a build in my nanny. Hit the gym. I just my second home
  4. 0:15Sweat on the floor with my hustles grown
  5. 0:17Don't bells click is the end of song
  6. 0:20pushing past limits if I'm in the song
  7. 0:23Mary checks you the beast inside
  8. 0:26confidence grows is the only guys
  9. 0:29The pull-up bars where I'm touch the sky
  10. 0:31This a just a gym. It's where I thrive
  11. 0:34I'm in heart and the race if you step forward and find my pace
  12. 0:37I'm the low this ring on the way turn the struggle and something great
  13. 0:40I'm so pressed to scope my frame feel you in here. I'm chasing the game friends outside
  14. 0:43So I say but in this playground. I'm building my name playing in metal
  15. 0:47It's music to my soul every set in breath getting closer to my goal
  16. 0:52Switch it down, but I'm feeling alive
  17. 0:54It's just my pride
  18. 0:56Come to survive. It's just my playground my soul my pride
  19. 1:00Make these call the kids get that cry. What's so deep? They redefined pages proof that I do it right turn the darkest into my life
  20. 1:14I'll be pro about to go all in one more breath to my power stand wait
  21. 1:18They have it with a mindset strong. This is my park. I've been here all along
  22. 1:20I'm a nice living with my creed feel my soul
  23. 1:22It's when I bleed from the streets the Hollywood dreams I reach I will build up a stand

CJC-1295 and ipamorelin stacked with testosterone: what the evidence says

cliff-the-welder

TikTok creator

3.1K viewsWatch on TikTok

Quick answer

The caption describes a stack of CJC-1295 and ipamorelin initiated alongside 250mg weekly exogenous testosterone, with a reported total testosterone level of 880 ng/dL. Neither peptide is FDA-approved for body composition or performance enhancement, and their compounded status is subject to ongoing regulatory restriction. The addition of GH secretagogues to a supraphysiologic androgen environment has limited clinical trial data to guide safety or efficacy expectations.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For CJC-1295 and ipamorelin stacked with testosterone: what the evidence says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

CJC-1295 and ipamorelin stacked with testosterone: what the evidence says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this cjc-1295 video claims cluster

Best for searchers checking whether growth-hormone peptide claims fit evidence, access, and safety realities.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "CJC-1295 and ipamorelin stacked with testosterone: what the evidence says" from cliff-the-welder. We read the clip as a Peptide social video fact-checks claim about CJC-1295, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The caption describes a stack of CJC-1295 and ipamorelin initiated alongside 250mg weekly exogenous testosterone, with a reported total testosterone level of 880 ng/dL.

The reason this review is not generic is the source wording and the canonical claim label "peptides jumping on the peptide trend first week on cjc1295 ipamoreli." In this clip, the useful excerpt is: "Yeah lights up It's time to grind where the weights align and I clear my mind I am playground where I break my chains every rep I take a build in my nanny." That wording changes the review because it points to CJC-1295 evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. CJC-1295 decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Ipamorelin is considered more selective than older GH secretagogues because it does not significantly raise cortisol or prolactin, but this selectivity data comes from animal and early-phase human studies, not long-term trials in athletes.
People who land here are usually comparing the CJC-1295 claim with [object Object].
The strongest next step is to compare the claim with FormBlends' CJC-1295 guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The caption describes a stack of CJC-1295 and ipamorelin initiated alongside 250mg weekly exogenous testosterone, with a reported total testosterone level of 880 ng/dL.

FormBlends verdict

CJC-1295 evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The caption describes a stack of CJC-1295 and ipamorelin initiated alongside 250mg weekly exogenous testosterone, with a reported total testosterone level of 880 ng/dL. Neither peptide is FDA-approved for body composition or performance enhancement, and their compounded status is subject to ongoing regulatory restriction. The addition of GH secretagogues to a supraphysiologic androgen environment has limited clinical trial data to guide safety or efficacy expectations.
  • CJC-1295 produced sustained GH and IGF-1 elevation in a 2006 Jette et al. clinical trial, but subjects were not on exogenous testosterone and the body composition implications remain unclear in that population.
  • Ipamorelin is considered more selective than older GH secretagogues because it does not significantly raise cortisol or prolactin, but this selectivity data comes from animal and early-phase human studies, not long-term trials in athletes.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • CJC-1295 produced sustained GH and IGF-1 elevation in a 2006 Jette et al. clinical trial, but subjects were not on exogenous testosterone and the body composition implications remain unclear in that population.
  • Ipamorelin is considered more selective than older GH secretagogues because it does not significantly raise cortisol or prolactin, but this selectivity data comes from animal and early-phase human studies, not long-term trials in athletes.
  • DEXA scanning is a legitimate and well-validated body composition method. Cliff using DEXA instead of estimated methods puts him ahead of most fitness content creators on this point.
  • CJC-1295 and ipamorelin are not FDA-approved drugs for any body composition or performance indication. Their compounded forms have faced increasing regulatory restriction since 2023 FDA guidance updates.
  • One week of peptide use is too short to draw any conclusion about body composition, recovery, or performance. Meaningful IGF-1 changes typically require several weeks of consistent administration.
  • Sigalos and Pastuszak's 2018 review in Current Urology Reports found that GH axis manipulation combined with androgens has theoretical synergy but lacks robust clinical trial data in healthy, resistance-trained men.
  • Self-reported dietary intake in athletes is frequently inaccurate by 20-30% in research settings. The 3,000-calorie and 280g protein figures should be taken as approximate targets, not verified intake.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @cliffthewelder actually say?

Honestly, the video itself tells us almost nothing. The transcript is a gym motivation song, not a peptide breakdown. Every claim worth examining comes from the caption: first week on CJC-1295 and ipamorelin, 250mg testosterone weekly, last bloodwork showing 880 ng/dL total testosterone, and a detailed body composition snapshot including 18.5% body fat on DEXA and a 3,000-calorie diet with 280g protein.

That caption is doing a lot of work. Cliff is implicitly suggesting this stack is part of his optimization routine, and by posting his stats, he's inviting the audience to draw a line between the compounds and the physique. He doesn't make explicit efficacy claims, but the framing does that job quietly. That's worth being honest about.

Does the science back this up?

The combination of a GHRH analog (CJC-1295) with a ghrelin mimetic (ipamorelin) has genuine mechanistic logic behind it. It's not bro-science. But the evidence base is thinner than the peptide community admits, and almost none of it applies to healthy, already-enhanced athletes.

CJC-1295 increases growth hormone pulse amplitude by binding to GHRH receptors on somatotrophs. Ipamorelin stimulates GH release via the ghrelin receptor and is considered relatively selective, meaning it does not significantly raise cortisol or prolactin at moderate doses, unlike older GH secretagogues such as GHRP-6. A 2006 study by Jette et al. in Growth Hormone and IGF Research confirmed that CJC-1295 produced sustained GH and IGF-1 elevation in healthy adults, but the subjects were not on exogenous testosterone, and the duration was short. The synergy of combining both compounds is pharmacologically sensible but not well-studied in clinical trials on resistance-trained individuals.

Adding 250mg weekly testosterone to this picture changes the hormonal environment dramatically. IGF-1 is already elevated by supraphysiologic androgens. Whether layering GH secretagogues on top provides additive body composition benefit beyond what TRT alone delivers, especially at 880 ng/dL, remains genuinely unclear.

What did they get wrong (or right)?

Credit where it's due: Cliff's reported testosterone level of 880 ng/dL on 250mg weekly is on the lower end of what that dose typically produces, which actually suggests he may have had that value drawn at trough. His DEXA-confirmed body composition data is more rigorous than the vast majority of fitness creators who eyeball body fat. Using DEXA instead of calipers or bioelectrical impedance is the right call.

What's missing is any acknowledgment that this stack is not FDA-approved for his stated purpose. CJC-1295 and ipamorelin are research compounds. They are not approved for body composition or athletic performance. The FDA has restricted many compounded peptides under 503B pharmacy regulations, and their legal status for prescribing is genuinely complicated. Posting this without any of that context, while implying the stack is just part of a normal optimization routine, is a real gap. A first week also tells you essentially nothing about efficacy.

What should you actually know?

If you see a peptide stack post and want to evaluate it honestly, start with three questions: What is the regulatory status of these compounds? What does the evidence actually show in people like you? And what are the risks nobody is mentioning?

On the first point, CJC-1295 and ipamorelin are not approved drugs. Their compounded forms have faced increasing FDA scrutiny. On the second, the best available evidence for GH secretagogues in body composition involves older or growth-hormone-deficient populations, not healthy adults already using testosterone. Sigalos and Pastuszak's 2018 review in Current Urology Reports is worth reading for context on GH and testosterone interactions. On the third, GH axis stimulation is not without risk: elevated IGF-1 over time, fluid retention, and potential effects on insulin sensitivity are real concerns that deserve mention in any honest discussion of this stack.

One week of anecdotal data combined with a motivational song is not evidence. It's a starting point for a conversation, not a recommendation.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

cliff-the-welder · TikTok creator

3.1K views on this video

Jumping on the peptide trend first week on cjc1295 -ipamorelin also take 250mg test weekly last check was 880 Stats 6’ 222.4lb Last dexa said 18.5%bf 18”arms 37”waist. Current diet 3000 calories 280g protein 100g fat #gymrat #peptide #liftthatshit

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about cjc-1295 produced sustained gh?

CJC-1295 produced sustained GH and IGF-1 elevation in a 2006 Jette et al. clinical trial, but subjects were not on exogenous testosterone and the body composition implications remain unclear in that population.

What does the video say about ipamorelin?

Ipamorelin is considered more selective than older GH secretagogues because it does not significantly raise cortisol or prolactin, but this selectivity data comes from animal and early-phase human studies, not long-term trials in athletes.

What does the video say about dexa scanning?

DEXA scanning is a legitimate and well-validated body composition method. Cliff using DEXA instead of estimated methods puts him ahead of most fitness content creators on this point.

What does the video say about cjc-1295?

CJC-1295 and ipamorelin are not FDA-approved drugs for any body composition or performance indication. Their compounded forms have faced increasing regulatory restriction since 2023 FDA guidance updates.

What does the video say about one week of peptide use?

One week of peptide use is too short to draw any conclusion about body composition, recovery, or performance. Meaningful IGF-1 changes typically require several weeks of consistent administration.

What does the video say about sigalos?

Sigalos and Pastuszak's 2018 review in Current Urology Reports found that GH axis manipulation combined with androgens has theoretical synergy but lacks robust clinical trial data in healthy, resistance-trained men.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by cliff-the-welder, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.